Global Burden of RSV Profiled in Children Aged 0 to 60 Months in 2019
Respiratory syncytial virus (RSV) infection contributes to substantial morbidity and mortality worldwide in children aged 0 to 60 months.
Lung Infections
Gram Stain-Guided Antibiotics: Effective, May Combat Spread of Multidrug-Resistant Pathogens
Researchers compared the effect of Gram stain-guided antibiotics with guideline-based antibiotics for the treatment of patients with ventilator-associated pneumonia.
Chronic Bacterial Infections Associated With an Increased Risk for Ischemic Stroke
In this meta-analysis, researchers assessed the relationship between 4 infectious bacteria and the risk for ischemic stroke.
Long-COVID Lung Disease: Researchers Characterize 3 Phenotypes
Can long-COVID lung diseases be better understood and classified via analysis of abnormalities seen on transbronchial lung cryobiopsies?
Identifying Lung Impairment in Preschoolers With Primary Ciliary Dyskinesia
Can the Lung Clearance Index, which uses the multiple breath washout test, be used in preschool children to detect lung impairment from primary ciliary dyskinesia?
RSV Prefusion F Protein-Based Immunization Studied in Pregnancy
A bivalent RSV prefusion F protein-based vaccine given during pregnancy elicits neutralizing antibody responses.
Exercise Limitation 3 Months Post Severe COVID-19 Lung Infection
How often do survivors of severe COVID-19 pulmonary infection experience long-term exercise capacity limitation, and what factors are associated with this condition?
Consensus Treatment Outcome Definitions for Chronic Pulmonary Aspergillosis
Consensus definitions for chronic pulmonary aspergillosis treatment outcomes, developed by a panel of international experts convened by CPAnet, were recently published.
RSV Vaccine Candidate for Older Adults Gets Breakthrough Therapy Designation
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
Azithromycin Therapy Does Not Reduce Recurrent Wheeze After RSV
Azithromycin therapy during acute severe respiratory syncytial virus bronchiolitis does not reduce recurrent wheeze over two to four years.
- Loading...
Loading...
Next post in Lung Infection
Loading... 
Loading...